Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy

Dev Cell. 2021 Sep 13;56(17):2440-2454.e6. doi: 10.1016/j.devcel.2021.07.006. Epub 2021 Aug 4.

Abstract

Mitotic errors lead to aneuploidy, a condition of karyotype imbalance, frequently found in cancer cells. Alterations in chromosome copy number induce a wide variety of cellular stresses, including genome instability. Here, we show that cancer cells might exploit aneuploidy-induced genome instability and the resulting gene copy-number changes to survive under conditions of selective pressure, such as chemotherapy. Resistance to chemotherapeutic drugs was dictated by the acquisition of recurrent karyotypes, indicating that gene dosage might play a role in driving chemoresistance. Thus, our study establishes a causal link between aneuploidy-driven changes in gene copy number and chemoresistance and might explain why some chemotherapies fail to succeed.

Keywords: aneuploidy; cancer; chemotherapy; drug resistance; genome instability.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aneuploidy*
  • Chromosomal Instability / genetics*
  • Drug Resistance / genetics*
  • Drug Therapy* / methods
  • Gene Dosage / genetics*
  • Genomic Instability / genetics
  • Humans
  • Karyotype